Oric Pharmaceuticals, Inc. (ORIC) stock forecast and price target
Price $7.86 · data as of November 13, 2026
12-month price target
Average target$21.71
Upside / downside+176.3%
Analysts14
ConsensusStrong buy
Low $14.00Average $21.71High $27.00
Gold marker: average target · white marker: today’s price ($7.86)
Analyst ratings
Strong buy 2Buy 12Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-1.49 | −1.5% | $0 |
| Next fiscal year ends December 31, 2027 | $-1.69 | −13.0% | $0 |
| Quarter after ends December 31, 2026 | $-0.40 | −31.7% | $0 |
Consensus of the analysts covering Oric Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.
Frequently asked questions
What is the Oric Pharmaceuticals stock price target?
The average 12-month target from 14 analysts is $21.71, 176.3% above the current price of $7.86 Targets range from $14.00 to $27.00.
Is Oric Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Oric Pharmaceuticals expected to earn?
Analysts expect EPS of $-1.49 for the fiscal year ending December 31, 2026 and $-1.69 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.